The Business Research Company’s report on the Aminoglycosides Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
How are market drivers shaping the future growth trajectory of the aminoglycosides industry?
The rising incidences of animal disease outbreak is a major driver expected to propel the growth of the aminoglycosides market going forward. Animal disease is an impairment of the normal state of an animal that interrupts or modifies its vital functions. Aminoglycosides such as amikacin and gentamicin are the most commonly used in veterinary medicine. For instance, in July 2022, an anthrax outbreak, a disease of humans and other mammals is reported and monitored in the remote areas of the largest national park in Canada– Wood Buffalo National Park. Therefore, the rising incidences of animal disease outbreaks will continue to drive the aminoglycosides market.
Access Your Free Sample of the Global Aminoglycosides Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=8515&type=smp
What is the estimated market size of the aminoglycosides sector by 2029, based on current forecasts?
The aminoglycosides market size has grown steadily in recent years. It will grow from $1.84 billion in 2024 to $1.93 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to antibiotic discovery and development, advancements in medicinal chemistry, clinical effectiveness in treating gram-negative infections, broad-spectrum antibacterial activity, hospital-acquired infection control, global population growth, post-surgery infection prevention, research and development investments.
The aminoglycosides market size is expected to see strong growth in the next few years. It will grow to $2.46 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to advancements in antibiotic stewardship, personalized medicine approaches, innovations in drug delivery, global spread of antibiotic-resistant strains, increasing focus on rare diseases, expanding applications in dermatology, patient education on antibiotic use. Major trends in the forecast period include biotechnological innovations, combination therapies, technological advancements in production, price competition.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=8515&type=smp
Who are the top players in the aminoglycosides market?
Major companies operating in the aminoglycosides market are Kremoint Pharma Pvt. Ltd., Vega Pharma Ltd., Jiangxi Bolai Pharmacy Co. Ltd., Xian Wison Biological Technology Co. Ltd., Hangzhou Uniwise International Co. Ltd., HuvePharma Inc., Yi Chang Veterinary Medicine Factory, Medson Pharmaceuticals, Medico Remedies Pvt. Ltd., Cipla Limited, Pfizer Inc., Allergan PLC, Teva Pharmaceutical Industries Ltd., Zoetis Inc., Novartis AG, Johnson & Johnson Inc., Bristol Myers Squibb Company, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Zydus Lifescience limited, Lupin Limited, Aurobindo Pharma Limited, Fresenius Kabi AG, Aspen Pharmacare Holdings Limited, Mylan N.V., Sanofi SA, Wyeth Pharmaceuticals Inc., Zhejiang Hisun Pharmaceutical Co. Ltd., GlaxoSmithKline plc
What are the major trends in the aminoglycosides market?
Process innovation is a key trend in the aminoglycosides market. Major companies operating in the aminoglycosides market are focused on developing new process solutions to strengthen their position in the market. For instance, in February 2024, Cipla Limited, an India-based pharmaceutical company, received approval from the Central Drugs Standard Control Organization (CDSCO) for ZEMDRI (plazomicin), an intravenous aminoglycoside antibiotic, in India. This antibiotic is specifically indicated for the treatment of complicated urinary tract infections (cUTIs), including pyelonephritis.
Which geography holds the highest aminoglycosides market share?
Asia-Pacific was the largest region in the aminoglycosides market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the aminoglycosides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/aminoglycosides-global-market-report
How do different segments contribute to the overall expansion of the aminoglycosides market?
The aminoglycosides market covered in this report is segmented –
1) By Product: Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin, Other Products
2) By Route Of Administration: Injectables (Parenteral), Feed, Intra-Mammary, Topical, Oral
3) By Application: Veterinary, Skin Infection, Respiratory Diseases, UTI And Pelvic Diseases, Other Diseases
Subsegments:
1) By Neomycin: Topical Formulations, Oral Formulations
2) By Tobramycin: Inhalation Solutions, Injectable Formulations, Ophthalmic Solutions
3) By Gentamicin: Injectable Formulations, Topical Formulations, Ophthalmic Solutions
4) By Amikacin: Injectable Formulations, Inhalation Solutions
5) By Paromomycin: Oral Formulations, Injectable Formulations
6) By Streptomycin: Injectable Formulations, Combination Therapies
7) By Kanamycin: Injectable Formulations, Oral Formulations
8) By Other Products: Combinations Of Aminoglycosides, Novel Aminoglycoside Derivatives
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8515
How is the aminoglycosides market defined?
Aminoglycoside is a class of antibiotics that inhibits protein synthesis. These are used in the treatment of aerobic gram-negative bacilli infections of the abdomen and urinary tract, as well as bacteremia and endocarditis
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
